Setsuko Mise‐Omata

1.5k total citations · 1 hit paper
19 papers, 1.0k citations indexed

About

Setsuko Mise‐Omata is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Setsuko Mise‐Omata has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Setsuko Mise‐Omata's work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (4 papers). Setsuko Mise‐Omata is often cited by papers focused on Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (4 papers). Setsuko Mise‐Omata collaborates with scholars based in Japan, United States and France. Setsuko Mise‐Omata's co-authors include Akihiko Yoshimura, Shunsuke Chikuma, Minako Ito, Frédérique Michel, Oreste Acuto, Giorgio Mangino, Taisuke Kondo, Mana Iizuka-Koga, Hiroko Nakatsukasa and Ryota Sakai and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Setsuko Mise‐Omata

17 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery

2018 529 citations Minako Ito, Kyoko Komai et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Setsuko Mise‐Omata Japan	13	565	281	277	252	67	19	1.0k
Mitsuhiro Kanamori Japan	12	603 1.1×	257 0.9×	290 1.0×	249 1.0×	68 1.0×	15	1.2k
Ilan Vaknin Israel	11	550 1.0×	274 1.0×	236 0.9×	254 1.0×	54 0.8×	23	1.1k
Sarah Mundt Switzerland	14	395 0.7×	242 0.9×	345 1.2×	144 0.6×	123 1.8×	25	868
Mathias Pawlak United States	11	596 1.1×	113 0.4×	379 1.4×	388 1.5×	43 0.6×	11	1.2k
Katayoun Ayasoufi United States	18	467 0.8×	150 0.5×	274 1.0×	256 1.0×	87 1.3×	39	1.0k
Fengyang Lei United States	19	378 0.7×	229 0.8×	258 0.9×	165 0.7×	61 0.9×	48	1.1k
Christopher Sie Germany	12	447 0.8×	152 0.5×	175 0.6×	145 0.6×	49 0.7×	13	799
Nathalie Koning Netherlands	12	517 0.9×	504 1.8×	225 0.8×	95 0.4×	50 0.7×	13	1.0k
Helena S. Domingues Portugal	13	406 0.7×	327 1.2×	329 1.2×	121 0.5×	51 0.8×	17	1.2k
Andreas Schulte‐Mecklenbeck Germany	19	630 1.1×	282 1.0×	270 1.0×	177 0.7×	75 1.1×	53	1.3k

Countries citing papers authored by Setsuko Mise‐Omata

Since Specialization

Citations

This map shows the geographic impact of Setsuko Mise‐Omata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setsuko Mise‐Omata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setsuko Mise‐Omata more than expected).

Fields of papers citing papers by Setsuko Mise‐Omata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setsuko Mise‐Omata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setsuko Mise‐Omata. The network helps show where Setsuko Mise‐Omata may publish in the future.

Co-authorship network of co-authors of Setsuko Mise‐Omata

This figure shows the co-authorship network connecting the top 25 collaborators of Setsuko Mise‐Omata. A scholar is included among the top collaborators of Setsuko Mise‐Omata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setsuko Mise‐Omata. Setsuko Mise‐Omata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ito, Minako, et al.. (2025). Stage-specific roles of clonally expanded CD8+ T cells in regulating amyloid pathology in Alzheimer’s disease models. Nature Communications. 16(1). 9458–9458.

Brems, Hilde, Mana Iizuka, Setsuko Mise‐Omata, et al.. (2024). Legius syndrome mutations in the Ras-regulator SPRED1 abolish its membrane localization and potentially cause neurodegeneration. Journal of Biological Chemistry. 300(12). 107969–107969.

Aki, Daisuke, Tanakorn Srirat, Shigeyuki Shichino, et al.. (2024). The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models. Journal of Clinical Investigation. 134(23). 6 indexed citations

Nakagawara, Kensuke, Makoto Ando, Tanakorn Srirat, et al.. (2024). NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors. Journal for ImmunoTherapy of Cancer. 12(8). e008665–e008665. 18 indexed citations

Srirat, Tanakorn, Setsuko Mise‐Omata, Kensuke Nakagawara, et al.. (2024). NR4a1/2 deletion promotes accumulation of TCF1+ stem-like precursors of exhausted CD8+ T cells in the tumor microenvironment. Cell Reports. 43(3). 113898–113898. 21 indexed citations

Iizuka-Koga, Mana, Minako Ito, Noriko Yumoto, et al.. (2024). Reconstruction of Sjögren's syndrome-like sialadenitis by a defined disease specific gut-reactive single TCR and an autoantibody. Clinical Immunology. 264. 110258–110258. 1 indexed citations

Mise‐Omata, Setsuko, Makoto Ando, Tanakorn Srirat, et al.. (2023). SOCS3 deletion in effector T cells confers an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine. Cell Reports. 42(8). 112940–112940. 7 indexed citations

Yoshifuji, Ayumi, Tetsuo Nakayama, Setsuko Mise‐Omata, et al.. (2023). Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis. Vaccines. 11(7). 1214–1214. 3 indexed citations

Mise‐Omata, Setsuko, Mari Ikeda, Masaru Takeshita, et al.. (2022). Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant. The Journal of Immunology. 209(11). 2104–2113. 14 indexed citations

10.

Ando, Makoto, Taisuke Kondo, Wataru Tomisato, et al.. (2021). Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory–Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand. Cancer Research Communications. 1(1). 41–55. 13 indexed citations

11.

Takahashi, Hayato, Naoko Wada, Hiromi Ito, et al.. (2021). Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus. Proceedings of the National Academy of Sciences. 118(49). 20 indexed citations

12.

Yoshimura, Akihiko, Minako Ito, Setsuko Mise‐Omata, & Makoto Ando. (2021). SOCS: negative regulators of cytokine signaling for immune tolerance. International Immunology. 33(12). 711–716. 22 indexed citations

13.

Kondo, Taisuke, Makoto Ando, Nao Nagai, et al.. (2019). The NOTCH–FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory–like CAR-T Cells. Cancer Research. 80(3). 471–483. 67 indexed citations

14.

Ito, Minako, Kyoko Komai, Setsuko Mise‐Omata, et al.. (2018). Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Nature. 565(7738). 246–250. 529 indexed citations breakdown →

15.

Chikuma, Shunsuke, Mitsuhiro Kanamori, Setsuko Mise‐Omata, & Akihiko Yoshimura. (2017). Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy. Cancer Science. 108(4). 574–580. 84 indexed citations

16.

Arai, Yuki, Kazuhiro Aoki, Yasuhiro Shimizu, et al.. (2016). Peptide-induced de novo bone formation after tooth extraction prevents alveolar bone loss in a murine tooth extraction model. European Journal of Pharmacology. 782. 89–97. 14 indexed citations

17.

Sugamori, Yasutaka, Setsuko Mise‐Omata, Shigeki Aoki, et al.. (2016). Peptide drugs accelerate BMP‐2‐induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling. BioEssays. 38(8). 717–725. 24 indexed citations

18.

Acuto, Oreste, Setsuko Mise‐Omata, Giorgio Mangino, & Frédérique Michel. (2003). Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. Immunological Reviews. 192(1). 21–31. 53 indexed citations

19.

Michel, Frédérique, et al.. (2001). CD28 as a Molecular Amplifier Extending TCR Ligation and Signaling Capabilities. Immunity. 15(6). 935–945. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact